Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Novel antiarrhythmic agents described by Merck & Co.

Feb. 13, 1997

Novartis launches once-daily hypertension Rx

Feb. 12, 1997

Alexion receives grant for complement inhibitors

Feb. 12, 1997

Sulfonamide derivatives for inhibition of cell adhesion

Feb. 12, 1997

American Home Products describes antiproliferative agents

Feb. 12, 1997

T Cell Sciences awarded second grant for vaccine development

Feb. 11, 1997

ET antagonists reported by Japanese investigators

Feb. 11, 1997

German researchers focus on Na+/H+-exchange inhibitors

Feb. 10, 1997

Chymase inhibitors from Green Cross

Feb. 7, 1997

First Corlopam Renal Program study completed

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...